Axonis translates breakthrough regeneration research to groundbreaking paralysis therapy, to transform lives of spinal cord injury patients.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $120M
Founded date: 2008
Investors 7
| Date | Name | Website |
| - | Pathway Bi... | pathwaybio... |
| - | MassChalle... | masschalle... |
| 26.12.2024 | MRL Ventur... | mrlv.com |
| 11.01.2022 | Civilizati... | civilizati... |
| 08.07.2022 | Creative D... | creativede... |
| - | Tachyon Ve... | tachyon.vc |
| 08.01.2025 | Solasta Ve... | solasta-ve... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 08.11.2024 | Series A | $115M | - |
| 14.07.2021 | - | $5M | - |
Mentions in press and media 10
| Date | Title | Description |
| 09.11.2024 | Axonis Therapeutics: A New Dawn in Neuromedicine | In the bustling world of biotechnology, Axonis Therapeutics is making waves. The Boston-based company recently secured $115 million in an oversubscribed Series A financing round. This funding is not just a number; it’s a lifeline for innova... |
| 08.11.2024 | Axonis Therapeutics: $115 Million (Series A) Raised To Develop Novel Neuromedicines | Axonis Therapeutics, a biotechnology company focused on the development of novel neuromedicines, announced the completion of an oversubscribed $115 million Series A financing. The proceeds from the financing will be used to advance Axonis’ ... |
| 30.10.2024 | Axonis Therapeutics Announces $115 Million Series A Financing | - |
| 30.10.2024 | Axonis Therapeutics Raises $115M in Series A Financing | Axonis Therapeutics, a Boston, MA-based biotechnology company focused on the development of novel neuromedicines, raised $115M in Series A funding. The round was led by Cormorant Asset Management and venBio Partners with participation from ... |
| 14.07.2021 | AXONIS Therapeutics Announces $5 Million in Funding; Provides Update on Progress Advancing Novel Therapeutics for Neurological Disorders | AXONIS Therapeutics, Inc., an emerging biotechnology company advancing breakthrough research to develop therapies for neurological disorders, today announced it has secured an additional $5 million in funding. This financing round, which fo... |
| 14.07.2021 | AXONIS Therapeutics Announces $5M in Funding | CAMBRIDGE, MA, AXONIS Therapeutics has secured an additional $5 million in funding led by Alexandria Venture Investments. >> Click here for more funding data on AXONIS Therapeutics >> To export AXONIS Therapeutics funding da... |
| 14.07.2021 | Axonis Therapeutics Raises $5M in Funding | Axonis Therapeutics, Inc., a Cambridge, Mass.-based biotechnology company advancing breakthrough research to develop therapies for neurological disorders, secured an additional $5m in funding. The round was led by Alexandria Venture Investm... |
| 24.10.2019 | MassChallenge Awards over $1M in Cash Prizes to Top Boston and Rhode Island Startups | BOSTON, October 24, 2019 – MassChallenge, a global network of zero-equity startup accelerators, tonight awarded more than $1M to 12 startups from its 10th annual Boston accelerator and second annual Rhode Island accelerator. Through a partn... |
| 15.05.2019 | MassChallenge Boston Announces 2019 Cohort | 100+ high-impact companies to access global network of support and resources in Boston BOSTON, MAY 15, 2019 - MassChallenge, a global network of zero-equity startup accelerators, today announced the more than 100 early-stage startups that ... |
| - | Axonis | “Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2.” |